Efficacy News and Research

RSS
Islet Sciences licenses noninvasive technology from Winthrop for detecting Beta cell death

Islet Sciences licenses noninvasive technology from Winthrop for detecting Beta cell death

Increased use of powerful antipsychotic drugs to treat publicly insured children

Increased use of powerful antipsychotic drugs to treat publicly insured children

Atox Bio AB103 for Necrotizing Soft Tissue Infections granted FDA Fast Track designation

Atox Bio AB103 for Necrotizing Soft Tissue Infections granted FDA Fast Track designation

Phase III data for Suvorexant, an investigational insomnia medicine, announced

Phase III data for Suvorexant, an investigational insomnia medicine, announced

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

Recent data from Silence Therapeutics’ Atu111 pre-clinical study on acute lung injury

Recent data from Silence Therapeutics’ Atu111 pre-clinical study on acute lung injury

TauRx initiates LMTX Phase 3 trial in Pick's Disease

TauRx initiates LMTX Phase 3 trial in Pick's Disease

UC Irvine receives CIRM grant to advance stem cell-based treatments for AD, retinitis pigmentosa

UC Irvine receives CIRM grant to advance stem cell-based treatments for AD, retinitis pigmentosa

Enrollment complete in DOUBle Phase 3 clinical trial of AzaSite Plus and DexaSite for blepharitis

Enrollment complete in DOUBle Phase 3 clinical trial of AzaSite Plus and DexaSite for blepharitis

Adding bavituximab to docetaxel doubles overall survival in late-stage NS-NSCLC patients

Adding bavituximab to docetaxel doubles overall survival in late-stage NS-NSCLC patients

Study reaffirms importance and efficacy of mammography

Study reaffirms importance and efficacy of mammography

Kalidex announces presentation of data on KPI-10 against MDR strains at ICAAC

Kalidex announces presentation of data on KPI-10 against MDR strains at ICAAC

Study finds PARP1 and EZH2 as potential therapeutic targets for small cell lung cancer

Study finds PARP1 and EZH2 as potential therapeutic targets for small cell lung cancer

Durata completes target enrollment in dalbavancin Phase 3 trials for abSSSI

Durata completes target enrollment in dalbavancin Phase 3 trials for abSSSI

Constipation drug may bring US patients relief

Constipation drug may bring US patients relief

Hopes dashed for ginkgo biloba in Alzheimer’s disease

Hopes dashed for ginkgo biloba in Alzheimer’s disease

Alzheimer’s disease is not prevented by ginkgo biloba

Alzheimer’s disease is not prevented by ginkgo biloba

Clinical trial to test combination of two drugs in treating fibromyalgia

Clinical trial to test combination of two drugs in treating fibromyalgia

New cell screening method can identify potential anti-influenza drugs

New cell screening method can identify potential anti-influenza drugs

FDA continues review of Salix’s Crofelemer new drug application

FDA continues review of Salix’s Crofelemer new drug application

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.